Overview

Knowledge Yield for Research & Analytics (KYRA) for Commercial is an AI-powered commercial intelligence platform designed specifically for pharmaceutical and biotechnology organizations. It transforms fragmented competitive, regulatory, scientific, market, and commercial information into actionable intelligence that enables faster and more confident decisions.

The Commercial Intelligence Challenge

Commercial teams operate in a rapidly changing environment where competitor launches, regulatory decisions, congress presentations, pricing changes, market access decisions, and scientific updates continuously influence strategy. Traditional monitoring approaches create information silos, delayed insights, and significant manual effort.

What is KYRA?

KYRA centralizes intelligence across regulatory, clinical, commercial, market access, scientific, investor, and competitive domains. The platform continuously monitors multiple external sources and delivers curated, role-specific intelligence to commercial teams.

Core Capabilities/Key Modules

News Monitoring

Regulatory Intelligence

Conference & Congress Intelligence

AI Assistant

Website Monitoring with Visual change detection

IR & Earning calls Intelligence

Gen AI powered summaries, feedback, Newsletters and Alerts

Persona defined insights, Role-based access and User Analytics

Business Benefits

Accelerate decisions, reduce manual monitoring, improve launch preparedness, identify competitive risks early, align cross-functional teams, and improve commercial effectiveness.

Who Uses KYRA​

Commercial Excellence

Competitive Intelligence

Brand Teams

Medical Affairs

Regulatory Affairs

Portfolio Strategy

Business Development

Leadership teams

Differentiators

Therapeutic-area-first design, pharma-specific workflows, Expert led tech enabled curated Insights, Visual change detection & alerts, AI-powered summarization, end-to-end intelligence coverage, configurable alerts, and enterprise-grade security.

Representative Use Cases

Launch readiness monitoring, congress intelligence, competitor tracking, market access monitoring, regulatory surveillance, and executive intelligence reporting.

Future Roadmap

Predictive analytics, opportunity detection, and intelligent recommendations.

Why Chryselys

Deep pharmaceutical expertise, proven intelligence solutions, rapid deployment accelerators, AI-enabled workflows, TA SMEs to ensure curated actionable insights and strong domain knowledge across commercial and competitive intelligence.

We Have More To Offer

Where innovation meets expertise, and excellence is the only outcome.

Have Questions?